The International Journal of Pharma Insight Studies (IJPIS) is dedicated to promoting excellence, credibility, and transparency in academic publishing. The journal follows internationally recognized ethical principles to ensure that all published research meets the highest standards of integrity, originality, and scientific responsibility.
Our ethical framework safeguards the interests of authors, reviewers, editors, and readers while strengthening trust in the scholarly communication process.
IJPIS maintains a strong commitment to ethical publishing practices across all stages of manuscript handling. Every submission is managed with professionalism, confidentiality, and fairness. The journal actively discourages unethical practices and takes firm action against any form of publication misconduct.
The editorial board ensures that all manuscripts are evaluated purely on academic merit, scientific relevance, originality, and clarity. Editorial decisions are transparent, unbiased, and independent of commercial or personal influence.
All submitted manuscripts are treated as confidential intellectual property. Editorial members disclose any conflicts of interest and recuse themselves when impartial handling cannot be guaranteed.
Peer review is a cornerstone of IJPIS’s publishing standards. The journal follows a structured and ethical review process designed to enhance research quality and credibility.
Reviewers are selected based on subject expertise and are expected to:
This process ensures that published articles reflect academic rigor and global research standards.
Authors submitting to IJPIS are expected to adhere to ethical research and publication practices. Submitted manuscripts must represent original work and must not be under consideration elsewhere.
Authors are responsible for:
All authors must approve the final manuscript prior to submission.
Research involving human participants or animals must comply with institutional, national, and international ethical guidelines. Ethical approval and informed consent, where applicable, must be clearly stated in the manuscript.
The journal promotes responsible research conduct and expects authors to retain and provide original data when requested for verification.
IJPIS takes allegations of ethical misconduct seriously. Suspected cases of plagiarism, duplicate publication, unethical research practices, or authorship disputes are investigated thoroughly.
Depending on the severity of the issue, corrective actions may include:
These measures are taken to preserve the integrity of the scholarly record.
The publisher works closely with the editorial team to uphold ethical standards and ensure transparency in the publication process. When ethical concerns arise, timely and appropriate action is taken to protect the credibility of the journal and the academic community.
By adhering to this Publication Ethics and Malpractice Statement, the International Journal of Pharma Insight Studies reaffirms its commitment to responsible publishing, academic excellence, and global research integrity.
IJPIS strives to be a trusted platform for high-quality pharmaceutical and biomedical research worldwide.